Provided by Tiger Trade Technology Pte. Ltd.

CNS Pharmaceuticals, Inc.

5.98
+0.45718.28%
Volume:5K
Turnover:28.97K
Market Cap:8.74M
PE:-0.26
High:5.98
Open:5.63
Low:5.61
Close:5.52
52wk High:10.59
52wk Low:1.90
Shares:1.46M
Float Shares:1.35M
Volume Ratio:0.56
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.1416
EPS(LYR):-35.7503
ROE:-106.62%
ROA:-58.01%
PB:0.48
PE(LYR):-0.17

Loading ...

CNS Pharmaceuticals Posts On-Demand Virtual Investor “Why Now” Webcast Presentation

Reuters
·
Aug 27

CNS Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 22

Vertical Data Names Chris Downs Interim CFO, Replaces Christopher Creatura as Finance Chief

Reuters
·
Aug 22

CNS Pharmaceuticals Director Michal Fisher Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

Vertical Data Names Chris Downs Interim CFO

Reuters
·
Aug 18

CNS Pharmaceuticals Q2 Net Income USD -2.6 Million

THOMSON REUTERS
·
Aug 12

CNS Pharmaceuticals Q2 EPS USD -0.37

THOMSON REUTERS
·
Aug 12

CNS Pharmaceuticals Q2 FY26 Net Loss Widens 9% to $2.59 Million Year over Year

Reuters
·
Aug 12

CNS Pharmaceuticals Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Reuters
·
Aug 11

CNS Pharma director Faith L. Charles buys 7,100 shares for $34,000

Reuters
·
May 20

CNS Pharmaceuticals Registers 9.79 Million Shares for Selling Holders

MT Newswires Live
·
May 20

CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders

TIPRANKS
·
May 20

CNS Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

CNS Pharmaceuticals Q1 net loss widens to $4.94 million from year-ago quarter

Reuters
·
May 14

CNS Pharmaceuticals Inc expected to post a loss of $5.37 a share - Earnings Preview

Reuters
·
May 12

What's Going On With CNS Pharmaceuticals Stock On Wednesday?

Benzinga
·
May 06

Top Midday Gainers

MT Newswires Live
·
May 05

Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?

TIPRANKS
·
May 04

Top Premarket Gainers

MT Newswires Live
·
May 04

CNS Pharmaceuticals prices $22.5 million private placement at $2.30 per share

Reuters
·
May 04